- Home
- HKIT vs AEON Comparison
HKIT vs AEON Comparison
Compare HKIT & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HKIT | AEON |
|---|---|---|
| Founded | 1996 | N/A |
| Country | China | United States |
| Employees | N/A | 5 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.2M | 26.8M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | HKIT | AEON |
|---|---|---|
| Price | $1.06 | $1.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 71.4K | ★ 76.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $0.38 |
| 52 Week High | $4.21 | $1.45 |
Technical Indicators
Market Signals| Indicator | HKIT | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 32.27 | 52.93 |
| Support Level | $0.53 | $0.69 |
| Resistance Level | $1.44 | $1.42 |
| Average True Range (ATR) | 0.20 | 0.10 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 36.35 | 62.95 |
Price Performance
Historical ComparisonAbout HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.